PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Pitofenone→

Pitofenone PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
54063-52-4
Molecular formula
C22H25NO4
Molecular weight
367.4 g/mol
Drug class
Direct-acting visceral smooth-muscle relaxantantispasmodic
Mechanism of action
A papaverine-like myotropic spasmolytic that relaxes visceral smooth muscle and reduces spasmodic contractions. It is usually formulated in fixed-dose combinations with metamizole and fenpiverinium, and the pharmacological contribution of the full combination should not be attributed to pitofenone alone.
Indications / reported uses
  • Component of fixed-dose antispasmodic combinations used for short-term symptomatic relief of painful gastrointestinal, biliary or urinary smooth-muscle spasm, where authorised.

Sources: https://pubmed.ncbi.nlm.nih.gov/?term=pitofenone+pharmacology · https://www.rlsnet.ru/active-substance/metamizol-natriya-pitofenon-fenpiveriniya-bromid-246 · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Pitofenone PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Pitofenone Permitted Daily Exposure (PDE) report (the Pitofenone PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Pitofenone Occupational Exposure Limit (OEL) report (the Pitofenone OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.